The Health Research Authority has unveiled its much-awaited strategy on how it plans to improve clinical trial transparency in the UK with provisions that will introduce “fair consequences for those who don’t take transparency seriously.”
Under the “Make it Public” strategy, the HRA intends to introduce, among other things, a new system in 2021-22 of...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?